快速检索:        
    
在线办公系统
在线期刊
下载专区
排行榜
友情链接
扫描微信二维码,获取更多信息
周苏宁,邵伟,段长利,蔚青.复方丹参注射液在冠心病非心脏手术时防治心肌缺血的临床观察[J].中国中西医结合杂志,1999,(2):75-76
复方丹参注射液在冠心病非心脏手术时防治心肌缺血的临床观察
Observation of Preventing and Treating Effect of Salvia Miltiorrhiza Composita on Patients with Ischemic Coronary Heart Disease Undergoing Non Heart Surgery
免费下载全文  查看/发表评论  下载PDF阅读器
  
DOI:
中文关键词:  复方丹参注射液  冠心病  非心脏手术  术中心肌缺血
英文关键词:Salvia miltiorrhiza composita  coronary heart disease  non heart surgery  ischemia in operation
基金项目:
作者单位
周苏宁 Zhou Suning, Shao Wei, Duan Changli, et al Shandong University of TCM, Jinan (250014 
邵伟 Zhou Suning, Shao Wei, Duan Changli, et al Shandong University of TCM, Jinan (250014 
段长利 Zhou Suning, Shao Wei, Duan Changli, et al Shandong University of TCM, Jinan (250014 
蔚青 Zhou Suning, Shao Wei, Duan Changli, et al Shandong University of TCM, Jinan (250014 
摘要点击次数: 1169
全文下载次数: 831
中文摘要:
      目的:观察复方丹参注射液用于冠心病非心脏手术术中心肌缺血的治疗。方法:冠心病非心脏手术108例,随机分为对照组54例(术中缺血时用硝酸酯类等药物对症治疗),丹参组54例(术中加入复方丹参注射液治疗)。术中及术毕观察心电图(ECG)、心率(HR)、平均动脉压(MAP)、脉搏血氧饱和度(SpO2)、手术失血量,以ECG做为疗效评定标准。结果:丹参组总有效率为907%,对照组总有效率为352%(P<001)。丹参组HR无明显变化,而对照组HR增快(P<005)。MAP、SpO2治疗前后或组间比较无显著差异;失血量两组无明显差异。结论:复方丹参注射液对冠心病非心脏手术术中心肌缺血有明显的改善和保护作用,无明显副作用,是安全有效的措施。
英文摘要:
      Objective: To observe the preventing and treatming effect of Salvia miltiorrhiza composita (SMC) on patients with ischemic coronary heart disease (CHD) undergoing non heart surgery. Methods: The 108 patients were randomly divided into the control group and treatment group. In the treatment group, each patient of 54 were administered SMC intravenously during the operation. ECG, HR, MAP and SpO 2 were observed and bleeding quantity was measured perioperatively Results: Effective rate of ECG in treatment group was 90.7% (49/54 cases) and the control group was 35.2%(19/54 cases). There was significant difference between the two groups (P<0 01). HR of the treatment group was no great flutter but control group became faster (P<0 05). MAP and SpO 2 of the two groups were no significant difference perioperatively. There was no significant difference to bleeding quantity between the two groups. Conclusions: SMC could effectively improve and protect myocardial ischemia in patients with CHD undergoing non heart surgery, and no side effect was found.
关闭